Kyrgyzstan vs Yemen: Treatment success rate for patients treated for MDR-TB
Kyrgyzstan
75.0%
in 2022
Yemen
75.0%
in 2022
Kyrgyzstan rank
70th
Yemen rank
70th
Treatment success rate for patients treated for MDR-TB over time
- Kyrgyzstan
- Yemen
How they compare
Kyrgyzstan currently reports 75.0% against 75.0% in Yemen, a difference of 0.0%.
The two have swapped places 2 times across 10 shared years of data; in 2013 it was Yemen ahead.
Kyrgyzstan ranks 70th and Yemen ranks 70th of 163 countries.
Across the 2 decades both report, Kyrgyzstan averaged higher in 1 and Yemen in 1.
Head to head by decade
| Decade | Kyrgyzstan | Yemen | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 58.4% | 72.7% | 14.3% | Yemen |
| 2020s | 74.0% | 73.3% | 0.7% | Kyrgyzstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Kyrgyzstan or Yemen?
- Kyrgyzstan, at 75.0% against 75.0% in Yemen as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Kyrgyzstan and Yemen?
- 0.0%, with Kyrgyzstan ahead.
- How many years of comparable data are there for Kyrgyzstan and Yemen?
- 10 years are reported by both, from 2013 to 2022.
- How do Kyrgyzstan and Yemen rank globally for treatment success rate for patients treated for mdr-tb?
- Kyrgyzstan ranks 70th and Yemen ranks 70th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.